-transparent.png){kind=logo}
Forty-four normotensive females, who were selected on the basis of lower prevailing potassium intake, participated in a two-period crossover study to assess the effects of potassium supplementation on blood pressure. They were randomly allocated to one of two groups who took either 80 mmol/day of KCl (Slow-K, Ciba Geigy), or matching placebo, for the first of two 4-week treatment periods. The treatments were reversed during the second 4-week period. Despite significant increases in both urinary and plasma potassium no consistent fall in blood pressure was seen during 80 mmol/day potassium intake.
Related Publications
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
May 2012,
American journal of physiology. Renal physiology,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
May 1991,
Journal of hypertension,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
October 1987,
Hypertension (Dallas, Tex. : 1979),
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
February 1994,
Journal of pharmaceutical sciences,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
October 2012,
American journal of physiology. Renal physiology,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
January 1986,
Clinical and experimental hypertension. Part A, Theory and practice,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
November 2023,
American journal of physiology. Regulatory, integrative and comparative physiology,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
July 1987,
British journal of clinical pharmacology,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
January 1984,
Journal of cardiovascular pharmacology,
A E Barden, and
R Vandongen, and
L J Beilin, and
B Margetts, and
P Rogers
January 1985,
Annals of clinical research,
